Back

Medscape, LLC

  • Alzheimer Disease

Exploring Novel Approaches With Blood-Based Biomarkers in Alzheimer’s Disease

The goal of this activity is for learners to be better able to explain differences between available blood-based biomarker tests for the assessment of AD; identify patients who should receive a blood-based biomarker test for AD; and interpret the results of blood-based biomarker testing for the assessment of AD.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.75 credits

MOC types

ABIM — Medical KnowledgeUp to 0.75 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.75 credits
  • MOC · Up to 0.75 points
  • Commercial Support
  • Released
    Mar 30, 2026
  • Last day to claim credit
    Mar 31, 2027 6 months left